Exagen Inc.

XGN

Exchange: Nasdaq
Industry: Services-Medical Laboratories
SEC CIK: 0001274737

SEC filings (opens in a new tab)

In the last 90 days, Exagen Inc. insiders filed 1 open-market purchase and 2 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 10, 2026: $127.4M
Insider buysLast 90 days, $104.4K in total: 1
Insider sellsLast 90 days, $418.6K in total: 2
13F holdersQ2 2026, −3 vs. previous quarter: 57
13F valueReported value at the end of Q2 2026: $37.0M
Superinvestors holdingAt the end of Q2 2026: 0

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2025: $66.6M; +19.7% year over year
Net income, FY2025: -$20.0M; No comparable prior period
Free cash flow, FY2025: -$14.3M; No comparable prior period
Revenue, Q2 FY2026: $19.9M; +15.9% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $20.0M (30.0% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 727.5K; Shares sold short
Change: +53.6K; +8.0% vs. previous
Days to cover: 1.98; At average daily volume

Superinvestors holding XGN, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding XGN at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Exagen Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change
Oct 20, 2026 (view filing)8:00 AM ET	Oct 19	1 day	Chernett Jorey10% Owner	PPurchase	+14.0K	$7.46	+$104.4K	+0.5%2.62M after
Oct 19, 2026 (view filing)4:52 PM ET	Oct 16	3 days	Aballi JohnPresident and CEO	SSale	−34.3K	$7.87	−$269.8K	−4.1%805.5K after
Sep 2, 2026 (view filing)5:39 PM ET	Sep 1	1 day	Black Jeffrey G.Chief Financial Officer	SSale	−20.6K	$7.22	−$148.8K	−6.0%323.3K after
Mar 4, 2026 (view filing)	Mar 3	1 day	Aballi JohnPresident and CEO	SSale	−15.7K	$3.62	−$56.8K	−2.2%687.3K after
Feb 25, 2026 (view filing)	Feb 24	1 day	Aballi JohnPresident and CEO	SSale	−11.4K	$3.61	−$41.3K	−1.6%703.0K after
Feb 25, 2026 (view filing)	Feb 24	1 day	Black Jeffrey G.Chief Financial Officer	SSale	−1.58K	$3.61	−$5.72K	−0.6%267.4K after
Oct 20, 2025 (view filing)	Oct 16	4 days	Aballi JohnPresident and CEO	SSale	−31.8K	$11.82	−$375.7K	−4.3%714.4K after
Sep 4, 2025 (view filing)	Sep 2	2 days	Black Jeffrey G.Chief Financial Officer	SSale	−20.5K	$9.79	−$200.4K	−7.1%269.0K after
Mar 27, 2025 (view filing)4:15 PM ET	Mar 25	2 days	NMSIC Co-Investment Fund, L.P. and 1 other10% Owner	SSale	−350.0K	$3.30	−$1.16M	−16.6%1.76M after
Nov 27, 2024 (view filing)4:18 PM ET	Nov 20	7 daysLate	NMSIC Co-Investment Fund, L.P. and 1 other10% Owner	SSale	−200.0K	$3.30	−$660.0K	−8.7%2.11M after

Top 10 13F holders, Q2 2026

See all 57 holders

The largest institutional positions in Exagen Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding XGN in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Wexford Capital LP	792,855	$3.69M	0.51%	00.0%	Unchanged
Nano Cap New Millennium Growth Fund L P	675,000	$3.14M	2.41%	+90,000+15.4%	Added
Vanguard Capital Management LLC	612,832	$2.85M	0.00%	−65,820−9.7%	Reduced
FourWorld Capital Management LLC	596,528	$2.77M	3.54%	+156,578+35.6%	Added
Silvercrest Asset Management Group LLC	514,761	$2.39M	0.02%	−23,109−4.3%	Reduced
Kennedy Capital Management, Inc.	485,048	$2.26M	0.04%	−8,612−1.7%	Reduced
Mink Brook Asset Management LLC	475,944	$2.21M	0.98%	+106,917+29.0%	Added
Jane Street Group, LLC	322,502	$1.50M	0.00%	+85,767+36.2%	Added
Acadian Asset Management LLC	310,084	$1.44M	0.00%	−379,030−55.0%	Reduced
First Eagle Investment Management, LLC	306,965	$1.43M	0.00%	+181,723+145.1%	Added

Holders of 5% or more of XGN

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Exagen Inc..

Largest holders of XGN from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
Chernett Jorey	13G/A	9.90%2.41M shares	+4.50 ppfrom 5.40%	Feb 4, 20262 filings	May 20, 2026	SEC
NMSIC Co-Investment Fund, L.P.	13G/A	6.04%1.37M shares	−3.79 ppfrom 9.83%	Feb 11, 20217 filings	Feb 11, 2026	SEC
Parian Ultreia LP	13G	5.30%1.29M shares	New	May 27, 20261 filing	May 27, 2026	SEC
Cowen Financial Products LLC	13G/A	5.00%891.4K shares	–	Dec 17, 20216 filings	May 12, 2025	SEC